about
Neuroprotective Effect of Lacosamide on Hypoxic-Ischemic Brain Injury in Neonatal Rats.Therapeutic Drug Monitoring of the Newer Anti-Epilepsy MedicationsLow-dose lacosamide-induced atrial fibrillation: Case analysis with literature reviewSafe Treatment of Seizures in the Setting of HIV/AIDS.Seizures in the acute stroke setting.A flexible Bayesian approach for modeling monotonic dose-response relationships in drug development trials.An overview of third-generation antiseizure drugs: Clobazam, lacosamide, rufinamide, and vigabatrin.
P2860
Q33567241-B8D9B1A4-2592-4192-ACE7-4EFCD444EFA9Q33996679-4CF10FFE-F4B3-4C9B-8F61-B844419E5293Q34114744-E1B55ADF-1B18-44D0-A6A4-9413A4FE320BQ37096562-72E2EA6E-4408-4207-A9A0-C458A651BEA0Q38196953-163B722A-84D0-4917-B08E-35B1FC807787Q44100721-D5BDA312-9999-4051-9BC4-EC2C959D627BQ50007123-4EE81FAF-1B1B-4318-938D-95DBC1235CBF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical perspectives on lacosamide
@en
Clinical perspectives on lacosamide.
@nl
type
label
Clinical perspectives on lacosamide
@en
Clinical perspectives on lacosamide.
@nl
prefLabel
Clinical perspectives on lacosamide
@en
Clinical perspectives on lacosamide.
@nl
P2860
P1433
P1476
Clinical perspectives on lacosamide
@en
P2093
Marc Lapointe
P2860
P356
10.1111/J.1535-7511.2008.01273.X
P407
P577
2009-01-01T00:00:00Z